Drug intelligence / Profile preview

xiaoer feire kechuan granules

Development stage: Unknown
Lead developer: Qingdao Growful Pharmaceutical
Administration: Oral

Overview

Xiaoer Feire Kechuan Granules is a traditional Chinese medicine (TCM) product widely used in China for pediatric respiratory conditions. Developed and manufactured by Shanghai Pharmaceuticals Group Qingdao Growful Pharmaceutical (and other manufacturers), it is indicated for the treatment of cough, fever, and asthma caused by lung heat patterns, which often correspond to acute bronchitis or pneumonia in Western medicine. The formulation is based on the classic Maxing Shigan Tang and is supplemented with additional herbs to clear heat, detoxify, and resolve phlegm. It is available as an over-the-counter (OTC) granule for oral administration.

Brand names: Xiaoer Feire Kechuan Granules小儿肺热咳喘颗粒
Other names: Xiaoer Feire Kechuan Keli

Beyond the preview

Go deeper on xiaoer feire kechuan granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on xiaoer feire kechuan granules.

Explore the full profile